China is AstraZeneca’s second-largest market after the United States, where the company has recently invested heavily under pressure from President Donald Trump.
News
UK drugs giant AstraZeneca announces $15 bn investment in China
January 29, 2026China is AstraZeneca’s second-largest market after the United States, where the company has recently invested heavily under pressure from President Donald Trump.